Imaging of Her2-targeted magnetic nanoparticles for breast cancer detection: Comparison of SQUID-detected magnetic relaxometry and MRI

Contrast Media and Molecular Imaging

Volumn 7, Issue 3, 2012, Pages 308-319

  Adolphi, Natalie L ^a   Butler, Kimberly S ^a   Lovato, Debbie M ^a   Tessier, T E ^b   Trujillo, Jason E ^a   Hathaway, Helen J ^a   Fegan, Danielle L ^b   Monson, Todd C ^c   Stevens, Tyler E ^c   Huber, Dale L ^c   Ramu, Jaivijay ^a   Milne, Michelle L ^d   Altobelli, Stephen A ^e   Bryant, Howard C ^b   Larson, Richard S ^a   Flynn, Edward R ^b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b American Southwest Ichthyological Researchers   (United States)

^c SANDIA NATIONAL LABORATORIES   (United States)

^d WASHINGTON UNIVERSITY   (United States)

^e New Mexico Resonance   (United States)

Author keywords

Antibody targeting; Magnetic resonance imaging; Magnetic susceptibility; Magnetite; Magnetometry; Magnetorelaxometry; Nanoparticle; SQUID

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; IRON OXIDE; MAGNETIC NANOPARTICLE; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CELL LABELING; CELL STRAIN MCF 7; CONJUGATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MONITORING; MOUSE; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUDE MOUSE; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; SENSOR; SUPERCONDUCTING QUANTUM INTERFERENCE DEVICE DETECTED MAGNETIC RELAXOMETRY; TUMOR XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; FEMALE; FERRIC COMPOUNDS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MICE; MOLECULAR IMAGING; QUANTUM THEORY; RECEPTOR, ERBB-2; REFRACTOMETRY; TUMOR CELLS, CULTURED;

EID: 84860373205     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.499     Document Type: Article

References (39)

1. Hellquist BN, Duffy SW, Abdsaleh S, Björneld L, Bordás P, Tabár L, Viták B, Zackrisson S, Nyström L, Jonsson H. Effectiveness of population-based service screening with mammography for women ages 40 to 49years: evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort. Cancer 2011; 117(4): 714-722.
2. Kopans DB. Breast Imaging. Lippincott Williams & Wilkins: Philadelphia, PA, 2007.
3. Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, Jong RA, Hislop G, Chiarelli A, Minkin S, Yaffe MJ. Mammographic density and the risk and detection of breast cancer. New Engl J Med 2007; 356(3): 227-236.
4. Hendrick RE. Radiation doses and cancer risks from breast imaging studies. Radiology 2010; 257(1): 246-253.
5. Weinstein S, Rosen M. Breast MR imaging: current indications and advanced imaging techniques. Radiol Clin N Am 2010; 48(5): 1013-1042.
6. Jain TK, Reddy MK, Morales MA, Leslie-Pelecky DL, Labhasetwar V. Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats. Mol Pharm 2008; 5(2): 316-327.
7. Chen B, Wu W, Wang X. Magnetic iron oxide nanoparticles for tumor-targeted therapy. Curr Cancer Drug Targets 2011; 11(2): 184-189.
8. Gossuin Y, Gillis P, Hocq A, Vuong QL, Roch A. Magnetic resonance relaxation properties of superparamagnetic particles. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2009; 1(3): 299-310.
9. Laurent S, Boutry S, Mahieu I, Vander Elst L, Muller RN. Iron oxide based MR contrast agents: from chemistry to cell labeling. Curr Med Chem 2009; 16(35): 4712-4727.
10. Flynn ER, Bryant HC. A biomagnetic system for in vivo cancer imaging. Phys Med Biol 2005; 50(6): 1273-1293.
11. Ge S, Shi X, Baker JR Jr, Banaszak Holl MM, Orr BG. Development of a remanence measurement-based SQUID system with in-depth resolution for nanoparticle imaging. Phys Med Biol 2009; 54(10): N177-188.
12. Richter H, Kettering M, Wiekhorst F, Steinhoff U, Hilger I, Trahms L. Magnetorelaxometry for localization and quantification of magnetic nanoparticles for thermal ablation studies. Phys Med Biol 2010; 55(3): 623-633.
13. Weizenecker J, Gleich B, Rahmer J, Dahnke H, Borgert J. Three-dimensional real-time in vivo magnetic particle imaging. Phys Med Biol 2009; 54(5): L1-L10.
14. Ferguson RM, Minard KR, Krishnan KM. Optimization of nanoparticle core size for magnetic particle imaging J Magn Magn Mater 2009; 321(10): 1548-1551.
15. Radermacher KA, Beghein N, Boutry S, Laurent S, Vander Elst L, Muller RN, Jordan BF, Gallez B. In vivo detection of inflammation using pegylated iron oxide particles targeted at E-selectin: a multimodal approach using MR imaging and EPR spectroscopy. Invest Radiol 2009; 44(7): 398-404.
16. Radermacher KA, Boutry S, Laurent S, Elst LV, Mahieu I, Bouzin C, Magat J, Gregoire V, Feron O, Muller RN, Jordan BF, Gallez B. Iron oxide particles covered with hexapeptides targeted at phosphatidylserine as MR biomarkers of tumor cell death. Contrast Media Mol Imag 2010; 5(5): 258-267.
17. Knappe S, Sander TH, Kosch O, Wiekhorst F, Kitching J, Trahms L. Cross-validation of microfabricated atomic magnetometers with superconducting quantum interference devices for biomagnetic applications. Appl Phys Lett 2010; 97(13): 133703(1-3).
18. 4 nanoparticles by fluxgate magnetorelaxometry for use in biomedical applications. J Appl Phys 2008; 103(7): 07A314(1-3).
19. Heim E, Ludwig F, Schilling M. Binding assays with streptavidin-functionalized superparamagnetic nanoparticles and biotinylated analytes using fluxgate magnetorelaxometry. J Magn Magn Mater 2009; 321(10): 1628-1631.
20. Eberbeck D, Wiekhorst F, Steinhoff U, Schwarz K O, Kummrow A, Kammel M, Neukammer J, Trahms L. Specific binging of magnetic nanoparticle probes to platelets in whole blood detected by magnetorelaxometry. J Magn Magn Mater 2009; 321(10): 1617-1620.
21. Jaetao JE, Butler KS, Adolphi NL, Lovato DM, Bryant HC, Rabinowitz I, Winter SS, Tessier TE, Hathaway HJ, Bergemann C, Flynn ER, Larson RS. Enhanced leukemia cell detection using a novel magnetic needle and nanoparticles. Cancer Res 2009; 69(21): 8310-8316.
22. Tietze R, Jurgons R, Lyer S, Schreiber E, Wiekhorst F, Eberbeck D, Richter H, Steinhoff U, Trahms L, Alexiou C. Quantification of drug-loaded magnetic nanoparticles in rabbit liver and tumor after in vivo administration. J Magn Magn Mater 2009; 321(10): 1465-1468.
23. Adolphi NL, Huber DL, Jaetao JE, Bryant HC, Lovato DM, Fegan DL, Venturini EL, Monson TC, Tessier TE, Hathaway HJ, Bergemann C, Larson RS, Flynn ER. Characterization of magnetite nanoparticles for SQUID-relaxometry and magnetic needle biopsy. J Magn Magn Mater 2009; 321(10): 1459-1464.
24. Hathaway HJ, Butler KS, Adolphi NL, Lovato DM, Belfon R, Fegan D, Monson TC, Trujillo JE, Tessier TE, Bryant HC, Huber DL, Larson RS, Flynn ER. Detection of breast cancer cells using targeted magnetic nanoparticles and ultra-sensitive magnetic field sensors. Breast Cancer Res 2011; 13(5): R108.
25. Chemla YR, Grossman HL, Poon Y, McDermott R, Stevens R, Alper MD, Clarke J. Ultrasensitive magnetic biosensor for homogeneous immunoassay. Proc Natl Acad Sci USA 2000; 97(26): 14268-14272.
26. Enpuku K, Tanaka T, Matsuda T, Dang F, Enomoto N, Hojo J, Yoshinaga K, Ludwig F, Ghaffari F, Heim E, Schilling M. Properties of magnetic nanoparticles in the Brownian relaxation range for liquid phase immunoassays. J Appl Phys 2007; 102(5): 054901(1-7).
27. Néel L. Some theoretical aspects of rock-magnetism. Adv Phys 1955; 4(14): 191-243.
28. Adolphi NL, Huber DL, Bryant HC, et al. Characterization of single-core magnetite nanoparticles for magnetic imaging by SQUID relaxometry. Phys Med Biol 2010; 55(19): 5985-6003.
29. Brown WF. Thermal fluctuations of a single-domain particle. Phys Rev 1963; 130(5): 1677-1686.
30. 2* effects in vivo and ex vivo using iron oxide nanoparticles in steady state-dependence on blood volume and water exchange. Magn Reson Med 2002; 47(3): 461-471.
31. Zhang C, Wängler B, Morgenstern B, Zentgraf H, Eisenhut M, Untenecker H, Krüger R, Huss R, Seliger C, Semmler W, Kiessling F. Silica- and alkoxysilane-coated ultrasmall superparamagnetic iron oxide particles: a promising tool to label cells for magnetic resonance imaging. Langmuir 2007; 23(3): 1427-1434.
32. Matsushita T, Kusakabe Y, Fujii H, Murase K, Yamazaki Y, Murase K. Inflammatory imaging with ultrasmall superparamagnetic iron oxide. Magn Reson Imag 2011; 29(2): 173-178.
33. Zotev VS, Matlachov AN, Volegov PL, Sandin HJ, Espy MA, Mosher JC, Urbaitis AV, Newman SG, Kraus RH Jr. Multi-channel SQUID system for MEG and ultra-low-field MRI. IEEE Trans Appl Supercond 2007; 17(2): 839-842.
34. Zotev VS, Volegov PL, Matlashov AN, Espy MA, Mosher JC, Kraus RH Jr. Parallel MRI at microtesla fields. J Magn Reson 2008; 192(2): 197-208.
35. Johannsen M, Gneveckow U, Thiesen B, Taymoorian K, Cho CH, Waldöfner N, Scholz R, Jordan A, Loening SA, Wust P. Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution. Eur Urol 2007; 52(6): 1653-1661.
36. van Landeghem FK, Maier-Hauff K, Jordan A, Hoffmann KT, Gneveckow U, Scholz R, Thiesen B, Brück W, von Deimling A. Post-mortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles. Biomaterials 2009; 30(1): 52-57.
37. Koch RH, Foglietti V, Rozen JR, Stawiasz KG, Ketchen MB, Lathrop DK, Sun JZ, Gallagher WJ. Effects of radio frequency radiation on the dc SQUID. Appl Phys Lett 1994; 65(1): 100-102.
38. ASTM E394-00. Standard test method for iron in trace quantities using the 1, 10-henanthroline method, 2000.
39. Street R, Woolley JC. A study of magnetic viscosity. Proc Phys Soc A 1949; 62(9): 562-572.